ADC Therapeutics SA
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-121.4M | $-122.3M | $944.0K | $469.0K |
| FY2019 | $-121.6M | $-121.9M | $358.0K | $1.1M |
| FY2020 | $-168.7M | $-169.5M | $801.0K | $42.9M |
| FY2021 | $-233.4M | $-236.8M | $3.4M | $60.6M |
| FY2022 | $-138.3M | $-139.0M | $687.0K | $49.3M |
| FY2023 | $-118.7M | $-121.9M | $3.2M | $13.5M |
| FY2024 | $-123.8M | $-124.7M | $867.0K | $6.6M |
| FY2025 | $-141.2M | $-141.4M | $264.0K | $6.9M |